Startseite
Reels
Gruppen
Seiten
Mehr sehen
Gruppen Seiten Veranstaltungen Blogs Angebote Jobs Gruppen Foren Filme Merits
Anmelden Registrieren
Theme Switcher
Nachtmodus
Acute Myeloid Testing Market at a CAGR of 13.70% in the forecast period of 2022-2029.
Introduction The acute myeloid leukemia (AML) testing market has become a critical segment within the broader field of oncology diagnostics. AML is an aggressive cancer of the blood and bone marrow characterized by the rapid growth of abnormal myeloid cells. It accounts for a significant proportion of leukemia cases worldwide and is associated with high morbidity and mortality rates....
0 Kommentare ·0 Geteilt ·42 Ansichten ·0 Bewertungen
Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!